AstraZeneca hopes warmer storage needs for COVID-19 vaccine will be an advantage against...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 23, 2020 at 10:42 PM.

  1. #1 cafead, Nov 23, 2020 at 10:42 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via AstraZeneca is the latest player to unveil early COVID-19 vaccine data, and results seem to show an efficacy gap between at least one of its vaccine regimens and those of its two mRNA-based peers. But while investors may be less than enthused with the data, the vaccine does sport a major advantage in logistics given its much warmer storage needs.

    article source
     
    Quote

Reply to Thread